Rajesh Ramaswamy is building the next generation of intelligent systems that transform how we understand, predict, and engineer complex systems across health, finance, and the physical world. His work focuses on turning traditionally empirical disciplines into continuously learning, AI-driven systems that improve with every interaction. Across startups, growth-stage companies, and global enterprises, he has led the development and deployment of AI systems that deliver measurable scientific, operational, and commercial impact.

He is currently Head of AI at Precede Biosciences, where he leads the strategy, development, and deployment of foundational AI systems for diagnostics and data products. His work is focused on transforming blood into a continuously updated representation of human biology, enabling earlier and more precise interventions, and ultimately a shift from reactive to adaptive healthcare. By combining multimodal data, machine learning, and scalable AI infrastructure, he is helping build systems capable of decoding complex diseases from genomic signals in blood at population scale.

Previously, Rajesh was Senior Vice President and Founding Head of AI at Sail Biomedicines, where he led the design and deployment of the company’s AI system for generating medicines. His work advanced a shift in drug creation from a process driven by chance to one grounded in engineering, where outcomes can be systematically improved and accelerated. The AI platform he helped pioneer contributed to multiple programs, including an in vivo CAR-T program.

Earlier, Rajesh founded and built the Data Driven Innovation office at EMD Serono, the North American biopharma business of Merck KGaA. There, he established enterprise AI capabilities and applied machine learning across the organization, enabling more effective commercial strategies and contributing to billion+ dollar product launches in Neurology, Immunology, and Oncology.

Rajesh began his career in quantitative finance, where he developed machine learning systems operating at the scale of billions of options trades per day across global markets.

He holds a Ph.D. in Computer Science from ETH Zürich, Switzerland.

George is actively involved in all aspects of portfolio management, including all investment due diligence and decision-making processes.

George joined Knightsbridge from Citigroup Private Equity where he was Director and Head of Venture/Growth Equity Fund Investments. At Citigroup, George was responsible for more than 100 fund relationships with commitments of $1.3 billion. Additionally, he was a member of several advisory boards and brought Citigroup into 29 new venture and growth equity funds, many of which were access-restricted. Prior to this role, George invested directly in private technology companies on behalf of Citigroup alongside venture investors, serving as a director or observer on many of their boards.

Earlier in his career, George spent five years as an engineer and project manager with a Silicon Valley technology company. George also holds a patent related to metallic access subscriber line testing.

George is a Swiss national, a former Swiss Army officer, and a graduate of the Swiss Institute of Technology (Dipl.El.-Ing.ETH). He came to the United States to earn an MS in Electrical Engineering from Stanford University, followed by an MBA from Santa Clara University.